av/peak-bio--big.svg

COM:PEAK-BIO

Peak Bio, Inc.

  • Stock

USD

Last Close

0.05

14/11 20:00

Market Cap

192.60K

Beta: -

Volume Today

1.93K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
net income
-8.68M
-
-2.10M
75.81%
-2.52M
20.11%
4.73M
287.39%
-13.19M
379.07%
-6.77M
48.71%
-5.94M
12.16%
410.59K
106.91%
-525.44K
227.97%
-681.65
99.87%
-2.08M
304,727.10%
3.97M
290.97%
depreciation and amortization
194.14K
-
307.30K
58.29%
208.48K
-
35.83K
82.81%
34.52K
3.65%
32.29K
6.47%
10.88
99.97%
21.74K
199,735.09%
-150.59K
792.66%
deferred income tax
3.08M
-
2.28M
26.13%
1.24M
-
stock based compensation
108.01K
-
165.78K
53.48%
165.01K
-
133.44K
19.13%
76.80K
42.45%
-99.82K
229.98%
404.09
100.40%
-267.94K
-
change in working capital
127.60K
-
632.55K
395.71%
918.85K
45.26%
-290.19K
131.58%
1.11M
482.01%
1.58M
42.70%
1.31M
17.07%
1.32M
0.72%
-555.47K
142.04%
-68.44
99.99%
647.09K
945,532.69%
-1.24M
291.32%
accounts receivables
-69.56
-
-61.40
11.73%
inventory
accounts payables
182.88K
-
1.43M
682.08%
1.24M
-
279.30K
77.44%
581.00K
108.02%
136.63K
76.48%
-295.58K
-
-1.37M
362.09%
other working capital
449.68K
-
-511.39K
213.72%
-1.24M
-
1.03M
183.41%
32.08
-
-7.05
121.96%
127.88K
-
other non cash items
140.35K
-
-2.79M
-
5.25M
288.00%
290.80K
94.46%
954.15K
228.11%
1.16M
21.18%
748.66K
35.25%
-7.02
100.00%
264.13K
3,760,664.08%
-5.92M
2,341.05%
net cash provided by operating activities
-8.42M
-
-1.17M
86.15%
-1.13M
2.99%
1.64M
245.37%
-6.83M
515.62%
-1.44M
78.92%
-1.23M
14.35%
-615.91K
50.07%
-1.47M
138.44%
-342.16
99.98%
-905.40K
264,514.69%
-2.37M
161.73%
investments in property plant and equipment
-3.12
-
acquisitions net
-36.54
-
-185.33
407.19%
purchases of investments
sales maturities of investments
other investing activites
0.00
-
66.50K
-
net cash used for investing activites
57.49M
-
-122.45K
-
122.45K
200%
-142.25K
216.17%
483.25K
-
-36.54
-
-188.45
415.73%
66.50K
-
debt repayment
-80K
-
-173.64K
-
-990.60K
-
-1.32M
-
common stock issued
-58.85M
-
1.25M
102.13%
1.15M
7.87%
-2.40M
308.54%
5.18M
315.47%
400K
-
-294.68K
173.67%
common stock repurchased
dividends paid
other financing activites
8.86M
-
23.04K
-
376.34K
1,533.12%
2.73M
626.03%
1.14M
58.11%
483.62K
57.74%
-230.39K
147.64%
757.80K
428.91%
-316.00K
-
2.95M
1,032.84%
net cash used provided by financing activities
-50.07M
-
1.25M
102.50%
1.18M
6.03%
-2.03M
272.43%
7.74M
481.75%
1.14M
85.21%
883.62K
22.79%
499.92K
43.42%
1.75M
250.72%
1.01M
-
2.95M
192.29%
effect of forex changes on cash
906.15K
-
-25.54K
102.82%
-39.05K
52.88%
-48.70K
24.72%
58.06K
219.22%
25.23K
56.54%
4
99.98%
-3.95K
98,800%
2.50K
163.45%
-2.44K
-
-27.06K
1,006.83%
net change in cash
-86.73K
-
59.31K
168.38%
-117.22K
297.65%
-308.59K
163.26%
818.62K
365.28%
-270.41K
133.03%
-349.81K
29.36%
-119.93K
65.71%
287.21K
339.48%
-637.89
100.22%
167.16K
26,305.53%
788.71K
371.82%
cash at beginning of period
529.20K
-
442.48K
16.39%
501.78K
13.40%
384.56K
23.36%
75.97K
80.24%
894.59K
1,077.50%
624.18K
30.23%
274.37K
56.04%
154.44K
43.71%
4.91K
96.82%
128.61K
2,517.15%
133.44K
3.75%
cash at end of period
442.48K
-
501.78K
13.40%
384.56K
23.36%
75.97K
80.24%
894.59K
1,077.50%
624.18K
30.23%
274.37K
56.04%
154.44K
43.71%
441.65K
185.98%
4.28K
99.03%
295.77K
6,816.56%
922.14K
211.77%
operating cash flow
-8.42M
-
-1.17M
86.15%
-1.13M
2.99%
1.64M
245.37%
-6.83M
515.62%
-1.44M
78.92%
-1.23M
14.35%
-615.91K
50.07%
-1.47M
138.44%
-342.16
99.98%
-905.40K
264,514.69%
-2.37M
161.73%
capital expenditure
-3.12
-
free cash flow
-8.42M
-
-1.17M
86.15%
-1.13M
2.99%
1.64M
245.37%
-6.83M
515.62%
-1.44M
78.92%
-1.23M
14.35%
-615.91K
50.07%
-1.47M
138.44%
-345.28
99.98%
-905.40K
262,123.66%
-2.37M
161.73%

All numbers in USD (except ratios and percentages)